Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tina Tan
Some two months after disclosing its intention to cast off its struggling cardiac rhythm management unit, LivaNova has struck a deal to sell the business to its Chinese joint venture partner MicroPort Scientific at a discounted price of $190m.
Briston University spin-out and developer of an antimicrobial material Pertinax Pharma has appointed Nigel Brooksby chairman.
Simon McGuire is to lead Philips' Health Systems group of businesses in UK and Ireland, effective Dec. 1.
The digital revolution looks to be sweeping across different industries, which are now fully embracing technologies around connectivity, big data and artificial intelligence to drive innovation and better outcomes. Health care seems to have come late to this party, but changes are happening as medtech companies make a concerted effort to incorporate the advanced computing capabilities needed to turn devices into smart machines that are constantly learning and adapting. Surgery is one area that will benefit from these smart technologies and Scott Huennekens, CEO of Verb Surgical, tells Medtech Insight how the J&J/Verily joint venture aims to make this happen.
Boston Scientific has had its fair share of struggles with its cardiac rhythm management unit, which it gained through its pivotal acquisition of Guidant back in 2006. A major slowdown in market growth was, and continues to be, a significant challenge, while the company has also had to contend with other internal operational issues. However, the business looks to be turning around to an extent, helped by a management change and some judicious innovation investments that are paying off. Medtech Insight caught up with Pierre Chauvineau, Boston Scientific's former VP of Rhythm Management, Europe and now VP Executive Advisor, to get an inside view.
The third edition of the Asia-Pacific Medtech Forum took place this week on Nov 7-9 in Singapore and included a solid line-up of speakers from industry, as well as regulatory and government authorities and thought leaders. Medtech Insight was at the event, busy Tweeting choice soundbites from the likes of Baxter International's José Almeida, Boston Scientific's Michael Mahoney, Microsoft's Simon Kos, Verb Surgical's Scott Huennekens and Japan's vice-minister of health at Japan's Ministry of Health, Labour and Welfare Yusuhiro Suzuki, among other notable figures.